As olution of 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol (Fluconazole,HFlu,0.10 mmol) in 10 mL DMF was added dropwise withstirringatroomtemperature to asolution of MnCl 2 × 4H 2 O(0.1981 g, 0.10 mmol) in 10 mL water. The mixture was stirred at room temperature until it was homogeneous, and then sealed in a25mLTeflon-lined stainless steel reactor, kept under pressure at 120°C for 24 h, and then slowly cooled to room temperature. After 7days, colorless block-shaped crystals suitable for X-ray diffraction were separated and washed with water. They weres table in air and insoluble in water and commonorganic solvents. 
Discussion
2-(2,4-Difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol (HFlu)isone of the first-line popular drugs used to treat invasive infections [1] .H Flu has been of our research interest for the construction of unusual coordination polymers due to its flexible backbone, versatile coordination fashions, as well as pharmacological activity [2] [3] . Thus, the HFlu ligands have potential to construct adiversity of coordination architectures upon the metal complexation. In the title crystal structure, each Mn(II) center is hexa-coordinatedbyfournitrogenatoms from four triazole moieties of four different HFlu ligands, one oxygen atom from the water molecule and one chloride ion. The asymmetric unit also contains hydrogen-bonded water, one chloride ion and N,N-dimethylformamide. The coordinated HFlu ligands adopt abis(bidentate) mode bridging the Mn(II) ions into chains. The title structure is rich in hydrogen bonds with the distances 
